| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |